SuperworthSTERIS EPS STE
Diluted earnings per share by quarter and over the last twelve months, from 2018.
- Last 12 months, to Jun 30, 2026
- $8.18
- Latest quarter, Q1 FY27
- $2.04
- +14% on a year earlier
- Fiscal year 2026
- $7.93
- +28% on the year before
STERIS' earnings per share was $8.18 over the twelve months to Jun 30, 2026, up 25% on a year earlier.
In its latest quarter, Q1 FY27, it was $2.04, up 14% on the same quarter a year before.
Over the five fiscal years to FY2026 it grew 11% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2026 | $7.93 | +28% |
| FY2025 | $6.20 | +62% |
| FY2024 | $3.82 | +257% |
| FY2023 | $1.07 | −55% |
| FY2022 | $2.39 | −48% |
| FY2021 | $4.63 | −3% |
| FY2020 | $4.77 | +34% |
| FY2019 | $3.56 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q1 FY27 | $2.04 | +14% | $8.18 | |
| Q4 FY26 | $2.24 | +51% | $7.93 | |
| Q3 FY26 | $1.96 | +12% | $7.17 | |
| Q2 FY26 | $1.94 | +28% | $6.96 | |
| Q1 FY26 | $1.79 | +23% | $6.53 | |
| Q4 FY25 | $1.48 | n/a | $6.20 | |
| Q3 FY25 | $1.75 | +23% | $4.71 | |
| Q2 FY25 | $1.51 | +30% | $4.38 | |
| Q1 FY25 | $1.46 | +17% | $4.03 | |
| Q4 FY24 | −$0.01 | −101% | $3.82 | |
| Q3 FY24 | $1.42 | +15% | $5.71 | |
| Q2 FY24 | $1.16 | n/a | $5.53 |
Against its peers
Companies in Healthcare nearest STERIS' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| STESTERIS | $8.18 | +25% a year |
| INCYIncyte | $7.85 | +78% a year |
| THCTenet Healthcare | $25.93 | +66% a year |
| UTHRUnited Therapeutics | $27.95 | +9% a year |
| LHLabcorp | $12.09 | +33% a year |
| DGXQuest Diagnostics | $9.41 | +18% a year |
| ZBHZimmer Biomet | $4.11 | +0% a year |
| MEDPMedpace | $17.05 | +27% a year |
| WSTWest Pharmaceutical Services | $7.81 | +17% a year |
| RVTYRevvity | $2.10 | −11% a year |
| DXCMDexCom | $2.52 | +76% a year |
| Peer median | $8.63 |
Where STERIS ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on STERIS
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.